In The News
Medibank says Deloitte data breach report not relevant in shareholder class action
Judge balks at $10M registration bill in stolen wages class action
Freehills the firm of choice for MinRes, WiseTech as bosses face scrutiny
Judge rejects franchisees’ ‘colourable’ cross-claims against United Petroleum
Salter Brothers sues insurer to cover $3.5M in costs to defend client’s lawsuit
ASIC wins case over life insurer’s misleading ‘pre-existing condition’ term
AstraZeneca sues to put the brakes on Brilinta generic
ASIC warns financial services firms of risk of governance lag with AI use
Santos’ net zero plan ‘little more than speculation’, trial court told
S&P entitled to Rolls-Royce defence in CDO class action: court
Please login to bookmarkClose

AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta. 

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au